A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Clonidine (Duraclon)

INDICATIONS AND USAGE Clonidine hydrochloride tablets are indicated in the treatment of hypertension.

First FDA approval1987-09-04
Generic availableYes · 23 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$123.7M in CY2024 Part D spend6.0M claims · 1.8M beneficiaries · 329 plans surveyed

Lowest NADAC
$0.025/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.025
Across all dosage forms in distribution.
Highest NADAC
$0.025
Range is tight.
Plans with PA
6 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Clonidine used for?

INDICATIONS AND USAGE Clonidine hydrochloride tablets are indicated in the treatment of hypertension.

Is there a generic for Clonidine?

Yes. 51 ANDAs filed at FDA, 23 generic manufacturers currently shipping.

How much does my plan pay for Clonidine?

Across 329 Part D plans, Clonidine averages $0.025/unit (NADAC). Lowest available: $0.025/unit. Highest in distribution: $0.025/unit.

Is Clonidine on the FDA shortage list?

No. Clonidine is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Central alpha-2 Adrenergic Agonist4 alternatives in D1
01
Clonidine Transdermal System
Brand: Catapres-TTS-1
$7.23Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Dexmedetomidine
Brand: Dexmedetomidine Hydrochloride in Sodium Chloride
Lowest NADAC
24Generic mfrs
$308,999CY24 Part D spend
Compare →
03
Dexmedetomidine Hydrochloride In
Brand: Dexmedetomidine Hydrochloride
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Guanfacine
Brand: GUANFACINE
$0.140Lowest NADAC
18Generic mfrs
$14.4MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.